Fund shareholders of Aadi Bioscience Inc
ISIN US00032Q1040 · United States · LEI 549300G3U7TKW1M58L09
- Fund shareholders
- 17
- Of which ETFs
- 3 14 other funds
- Value held
- 6.9M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 887,972 | 3.1M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 392,053 | 1.4M $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 215,284 | 742.7K $ | 0.87 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 195,664 | 686.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 95,444 | 329.3K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 61,386 | 215.5K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 54,387 | 190.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 50,223 | 176.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 20,000 | 69K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 15,745 | 54.3K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 6,991 | 24.1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 5,917 | 20.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,704 | 5.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 1,254 | 4.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 938 | 3.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 702 | 2.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 690 $ | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.87 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 17 | +1 | 2,005,864 | -2.5 % |
| 2026Q1 | 16 | 0 | 2,056,697 | +16.8 % |
| 2025Q4 | 16 | -2 | 1,760,912 | -9.8 % |
| 2025Q3 | 18 | -1 | 1,953,285 | +44.8 % |
| 2025Q2 | 19 | 0 | 1,349,274 | +18.0 % |
| 2025Q1 | 19 | +3 | 1,143,276 | +4.1 % |
| 2024Q4 | 16 | -34 | 1,097,983 | -36.5 % |
| 2024Q3 | 50 | -23 | 1,727,857 | -14.3 % |
| 2024Q2 | 73 | -9 | 2,015,871 | -4.3 % |
| 2024Q1 | 82 | -7 | 2,107,354 | +2.0 % |
| 2023Q4 | 89 | 2,065,788 |
Institutional managers
59 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| QVT Financial LP | 4,615,709 | 15.9M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 4,166,000 | 14.4M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,700,000 | 12.8M $ | as of Mar 31, 2026 |
| ACUTA CAPITAL PARTNERS, LLC | 3,410,402 | 11.8M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,849,402 | 9.8M $ | as of Mar 31, 2026 |
| KVP Capital Advisors, LP | 2,165,997 | 7.5M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,082,000 | 7.2M $ | as of Mar 31, 2026 |
| Yu Fan | 2,070,000 | 7.1M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,139,363 | 3.9M $ | as of Mar 31, 2026 |
| STEMPOINT CAPITAL LP | 939,369 | 3.2M $ | as of Mar 31, 2026 |
| Ally Bridge Group (NY) LLC | 817,939 | 2.8M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 550,441 | 1.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 457,540 | 1.6M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 428,622 | 1.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 351,385 | 1.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 309,674 | 1.1M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 306,800 | 1.1M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 281,497 | 971.2K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 273,482 | 943.5K $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 215,284 | 742.7K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 203,465 | 702K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 160,382 | 553.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 151,110 | 521.3K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 128,503 | 443.3K $ | as of Mar 31, 2026 |
| Verdad Advisers, LP | 115,484 | 398.4K $ | as of Mar 31, 2026 |
Declared shareholders of Aadi Bioscience Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Avoro Capital Advisors LLC and 2 others | 19.99 % | 18,292,675 | as of May 12, 2026 · SCHEDULE 13D |
| ACUTA CAPITAL PARTNERS, LLC and 2 others | 9.00 % | 4,843,775 | as of May 14, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of Aadi Bioscience Inc". https://titelia.com/en/stocks/aadi-bioscience-inc-US00032Q1040